Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin 20mg QD vs BID in Total Hip Replacement
NCT00349180Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Sanofi. Started Jun 2006; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00349180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349180.